mRNA |
GSK461364 |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
4e-08 |
mRNA |
selumetinib:tretinoin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.19 |
9e-08 |
mRNA |
selumetinib:PLX-4032 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.19 |
1e-07 |
mRNA |
selumetinib:navitoclax (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.19 |
2e-07 |
mRNA |
selumetinib:UNC0638 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.19 |
2e-07 |
mRNA |
selumetinib:MK-2206 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.19 |
2e-07 |
mRNA |
Methotrexate |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
3e-07 |
mRNA |
selumetinib:vorinostat (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.18 |
4e-07 |
mRNA |
3-Cl-AHPC |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
6e-07 |
mRNA |
FK866 |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
7e-07 |